MiR-375 Promotes Pancreatic Differentiation by Affecting Different Target Genes at Different Stages
Overview
Authors
Affiliations
Human embryonic stem cells (hESCs) possess the ability to differentiate into insulin-producing cells (IPCs), which can be used to treat type I diabetes. miR-375 is an essential transcriptional regulator in the development and maturation of the pancreas. In this study, we optimized a protocol to differentiate hESCs into IPCs and successfully obtained IPCs. Then, we performed overexpression and inhibition experiments of miR-375 on cells at different stages of differentiation and performed RNA-seq. The results showed that the expression of miR-375 fluctuated during hESC differentiation and was affected by miR-375 mimics and inhibitors. miR-375 influences global gene expression and the target genes of miR-375. The overexpression of miR-375 can cause changes in multiple signaling pathways during pancreatic development. miR-375 is a major participant in the differentiation of pancreatic -cells through different target genes at different stages. This study provides new ideas for further investigation of how microRNAs affect cell fate and gene transcription.
Xu T, Shen T, Yang S, Li Y, Liu L, Du L BMC Endocr Disord. 2024; 24(1):225.
PMID: 39455977 PMC: 11515428. DOI: 10.1186/s12902-024-01755-6.
Targeting β-Cell Plasticity: A Promising Approach for Diabetes Treatment.
Gojani E, Rai S, Norouzkhani F, Shujat S, Wang B, Li D Curr Issues Mol Biol. 2024; 46(7):7621-7667.
PMID: 39057094 PMC: 11275945. DOI: 10.3390/cimb46070453.
Gooch A, Chowdhury S, Zhang P, Hu Z, Westenfelder C PLoS One. 2023; 18(8):e0290460.
PMID: 37616230 PMC: 10449143. DOI: 10.1371/journal.pone.0290460.
Hatmal M, Al-Hatamleh M, Olaimat A, Alshaer W, Hasan H, Albakri K Biomedicines. 2022; 10(6).
PMID: 35740242 PMC: 9219990. DOI: 10.3390/biomedicines10061219.
Ren Y, Wang X, Liang H, Ma Y PLoS One. 2022; 17(4):e0266609.
PMID: 35395037 PMC: 8992996. DOI: 10.1371/journal.pone.0266609.